AGP Wire

AGP

The Business Research Company released a 2026 global Atryn market report on Oct. 30, 2026, projecting demand growth through 2035 as chronic disease rates, personalized medicine, and surgical risk management drive use of recombinant antithrombin…

AGP

The Business Research Company says the global market for Asparlas (calaspargase pegol) is rising on demand for targeted leukemia therapies and longer-acting formulations.

AGP

The Business Research Company says the adult spinal deformity market is set to grow from $2.73 billion in 2026 to $3.37 billion by 2030, driven by aging populations, obesity, and wider use of minimally invasive spine procedures.

AGP

The global market for adult T-cell leukemia/lymphoma treatment is forecast to grow from $2.16 billion in 2026 to $2.99 billion by 2030, driven by clinical-trial activity, targeted therapies and broader cancer-care capacity.

AGP

The global Avonex market is projected to rise from $1.95 million in 2025 to $2.58 million by 2030, driven by growing multiple sclerosis diagnoses and continued demand for long-term injectable therapies.

AGP

The Business Research Company says the global Audenz vaccine market is being shaped by rising concern over zoonotic disease, stockpiling for pandemics and broader immunization efforts.

AGP

The Business Research Company says the global Attenuvax market is set for steady growth through 2026-2035 as measles outbreaks, childhood immunization efforts and public health spending support demand.

AGP

The global Avastin (bevacizumab) market is projected to keep growing as cancer cases rise, healthcare spending increases and biosimilars expand access.

AGP

Argentina’s Catamarca Ministry of Mining has approved the Kachi Lithium Brine Project’s environmental impact declaration, giving Lilac Solutions its first commercial technology permit in South America and the region’s first commercial-scale DLE…

AGP

The advanced recurrent ovarian cancer market is projected to grow from $2.71 billion in 2025 to $2.93 billion in 2026, according to The Business Research Company.

AGP

The Business Research Company projects the global advanced melanoma market will grow from $4.5 billion in 2026 to $6.37 billion by 2030. The report points to rising melanoma cases, stronger treatment adoption and faster growth in Asia-Pacific,…

AGP

The Business Research Company says the Brineura market is set for long-term growth through 2035, driven by rising genetic disorder diagnoses, orphan-drug support and stronger rare-disease care networks.

AGP

Centre for Management Technology will bring industry, government and brand leaders to Mexico City on Oct. 28-29 for a conference focused on how Latin America can move circular packaging from policy to practice.

AGP

S Hotels Jamaica’s flagship properties in Montego Bay and Kingston each took home major honors at the 2026 World Travel Awards Caribbean & North America Gala Ceremony in Jamaica.

AGP

Coherent Market Insights will serve as knowledge partner for Adhesives & Bonding Expo Mexico 2026 in Mexico City and is launching a new report on Mexico’s adhesives market ahead of the Oct. 14-16 event.

AGP

Rockstar Global is expanding its remote talent network with new hires from Nicaragua, Venezuela and El Salvador to support U.S. private practices and businesses.

AGP

OMNi and Les Pago have signed a memorandum of understanding to explore a financing collaboration that could make consumer technology more accessible.

AGP

leagend is broadening its professional battery tester and automotive electronics business across South America, with Brazil and Argentina as priority markets.

AGP

The Business Research Company says the adenosine deaminase-severe combined immunodeficiency market will rise from $6.33 billion in 2026 to $8.11 billion by 2030. Growth is expected to be driven by more gene therapy, enzyme replacement and stem…

AGP

The Business Research Company says the Ajovy market is set to expand through 2035 as migraine diagnoses rise, preventive treatment gains ground and biologic therapies become more accepted.